<DOC>
	<DOCNO>NCT01548391</DOCNO>
	<brief_summary>This study design evaluate safety , tolerability , pharmacokinetics HX-1171 healthy male subject .</brief_summary>
	<brief_title>A Phase I Clinical Study Study Safety , Tolerability , Pharmacokinetics HX-1171 Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Adult male age 20 40 year screen . Be able comply requirement study . Subject must provide write informed consent prior study participation . History presence liver , kidney , nervous system disease , respiratory disorder , endocrinological disorder , hematooncologic , cardiovascular psychiatric gastrointestinal disorder . History known hypersensitivity drug include HX1171 .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>